๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Estimating the human immunodeficiency virus infection curve of intravenous drug users in Lombardia, Italy

โœ Scribed by Antonino Salvaggio

Publisher
Springer
Year
1995
Tongue
English
Weight
585 KB
Volume
11
Category
Article
ISSN
0393-2990

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Human immunodeficiency virus (HIV) serop
Human immunodeficiency virus (HIV) seropositivity in intravenous (IV) drug abusers in three cities of Italy: Possible natural history of HIV infection in IV drug addicts in Italy
โœ Fausto Titti; Adriano Lazzarin; Paolo Costigliola; Carlo Oliva; Loredana Nicolet ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 474 KB

The prevalence of human immunodeficiency virus (HIV) antibodies and the symptoms induced [persistent generalized lymphadenopathy (PGL), AIDS-related complex (ARC), acquired immunodeficiency syndrome (AIDS)] was evaluated in several groups of intravenous (IV) drug abusers in three large Italian citie

Analysis of the HIV-1nef gene in five in
Analysis of the HIV-1nef gene in five intravenous drug users with long-term nonprogressive HIV-1 infection in Italy
โœ Catucci, Marinunzia; Venturi, Giulietta; Romano, Laura; Valensin, Pier E.; Zazzi ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 200 KB ๐Ÿ‘ 2 views

Great variability in the course of human immunodeficiency virus type 1 (HIV-1) infection results from a complex interplay between host and virus factors. Some of the patients with prolonged nonprogressive infection have been reported to harbor virus variants with gross deletions in the accessory nef

Low prevalence of human T-cell leukemia
Low prevalence of human T-cell leukemia virus-I and -II infection among drug users in Amsterdam, the Netherlands
โœ Mrs. J. A. R. Van Den Hoek; E. J. M. Al; J. G. Huisman; J. Goudsmit; R. A. Couti ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 395 KB ๐Ÿ‘ 1 views

The prevalence of human T-cell leukaemia virus-I and -II infection was studied in a cohort of 346 intravenous and nonintravenous drug users in Amsterdam. Three participants (0.86%) had antibodies to HTLV-I by two commercially available HTLV-I enzyme immunoassays (EIA). Infection in these three subje